[Reuters] - Sarissa Capital Management LP, a hedge fund run by investor Carl Icahn's former healthcare lieutenant, has taken a 6.22 percent stake in the wounded biotechnology company Ariad Pharmaceuticals Inc. Ariad's ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment